teva pharmaceuticals introduces the first generic glp-1 for weight loss Injection OK'd Teva Pharmaceutical Industries (TEVA) Announces

pre-bed required, AM optional Ipamorelin Loading 100 mcg (weeks 1-2) Frequency 1-2x daily Maintenance 100-200 mcg, 1-2x daily Route SubQ

To meet the diagnostic criteria for spEDS, a person must meet major criterion 1 AND major criterion 2 AND have characteristic radiographic abnormalities AND at least two other minor criteria (general or gene-specific)

Blood glutathione levels rise within 24 weeks

GLP-1s may help with OA by: Reducing overall inflammation Protecting cartilage in your joints Helping people lose weight takes pressure off the knees and hips Making walking and movement easier over time Studies found that GLP-1 and SGLT2 medicines may lower the risk of needing a knee replacement (for OA), though results varied

Presented at the 2025 Society of Hematologic Oncology Annual Meeting

Pharmacologically, cagrilintide is a dual amylin and calcitonin receptor agonist (DACRA) meaning it activates two related receptor systems at once